Physician profile
Rui Wang
NPI 1154958171
$1,968.96
in general payments reported to CMS, 2019-2025
11 companies · $1,039 in 2025
The $1,039 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $930 · 2025: $1,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,968.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $408.79 | 2025 | |
| Astellas Pharma US INC | $319.54 | 2024-2025 | Izervay |
| Alcon Vision LLC | $254.50 | 2024 | Clareon, Centurion |
| Regeneron Healthcare Solutions, INC. | $233.75 | 2024-2025 | Eylea Hd |
| Genentech USA, INC. | $205.99 | 2024-2025 | Vabysmo |
| Ocular Therapeutix, INC. | $172.20 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $151.59 | 2025 | |
| Dutch Ophthalmic, USA | $135.24 | 2024 | Eva, Combined Machine, Tissueblue |
| Bausch & Lomb Americas INC. | $36.98 | 2025 | Xipere, Stellaris |
| Ani Pharmaceuticals, INC. | $29.00 | 2025 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $21.38 | 2025 | Iheezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rui Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.